26 related articles for article (PubMed ID: 18436711)
1. The structural pathway of interleukin 1 (IL-1) initiated signaling reveals mechanisms of oncogenic mutations and SNPs in inflammation and cancer.
Acuner Ozbabacan SE; Gursoy A; Nussinov R; Keskin O
PLoS Comput Biol; 2014 Feb; 10(2):e1003470. PubMed ID: 24550720
[TBL] [Abstract][Full Text] [Related]
2. A tumor-associated splice-isoform of
Ray D; Yun YC; Idris M; Cheng S; Boot A; Iain TBH; Rozen SG; Tan P; Epstein DM
Proc Natl Acad Sci U S A; 2020 Jul; 117(28):16391-16400. PubMed ID: 32601196
[TBL] [Abstract][Full Text] [Related]
3. Hypoxia-Induced Upregulation of lncRNA ELFN1-AS1 Promotes Colon Cancer Growth and Metastasis Through Targeting TRIM14
Jing X; Du L; Shi S; Niu A; Wu J; Wang Y; Wang C
Front Pharmacol; 2022; 13():806682. PubMed ID: 35652045
[TBL] [Abstract][Full Text] [Related]
4. JNK1 Inhibition Attenuates Hypoxia-Induced Autophagy and Sensitizes to Chemotherapy.
Vasilevskaya IA; Selvakumaran M; Roberts D; O'Dwyer PJ
Mol Cancer Res; 2016 Aug; 14(8):753-63. PubMed ID: 27216154
[TBL] [Abstract][Full Text] [Related]
5. The MKK7 p.Glu116Lys Rare Variant Serves as a Predictor for Lung Cancer Risk and Prognosis in Chinese.
Qiu F; Yang L; Lu X; Chen J; Wu D; Wei Y; Nong Q; Zhang L; Fang W; Chen X; Ling X; Yang B; Zhang X; Zhou Y; Lu J
PLoS Genet; 2016 Mar; 12(3):e1005955. PubMed ID: 27028764
[TBL] [Abstract][Full Text] [Related]
6. Physiological roles of MKK4 and MKK7: insights from animal models.
Wang X; Destrument A; Tournier C
Biochim Biophys Acta; 2007 Aug; 1773(8):1349-57. PubMed ID: 17157936
[TBL] [Abstract][Full Text] [Related]
7. Mitogen-activated protein kinase kinase 7 in inflammatory, cancer, and neurological diseases.
Caliz AD; Vertii A; Fisch V; Yoon S; Yoo HJ; Keaney JF; Kant S
Front Cell Dev Biol; 2022; 10():979673. PubMed ID: 36340039
[TBL] [Abstract][Full Text] [Related]
8. Effects of geldanamycin on signaling through activator-protein 1 in hypoxic HT29 human colon adenocarcinoma cells.
Vasilevskaya IA; O'Dwyer PJ
Cancer Res; 1999 Aug; 59(16):3935-40. PubMed ID: 10463587
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of JNK Sensitizes Hypoxic Colon Cancer Cells to DNA-Damaging Agents.
Vasilevskaya IA; Selvakumaran M; Hierro LC; Goldstein SR; Winkler JD; O'Dwyer PJ
Clin Cancer Res; 2015 Sep; 21(18):4143-52. PubMed ID: 26023085
[TBL] [Abstract][Full Text] [Related]
10. Differential regulation of HSP70 expression by the JNK kinases SEK1 and MKK7 in mouse embryonic stem cells treated with cadmium.
Nishitai G; Matsuoka M
J Cell Biochem; 2008 Aug; 104(5):1771-80. PubMed ID: 18348256
[TBL] [Abstract][Full Text] [Related]
11. Additive interaction of oxaliplatin and 17-allylamino-17-demethoxygeldanamycin in colon cancer cell lines results from inhibition of nuclear factor kappaB signaling.
Rakitina TV; Vasilevskaya IA; O'Dwyer PJ
Cancer Res; 2003 Dec; 63(24):8600-5. PubMed ID: 14695170
[TBL] [Abstract][Full Text] [Related]
12. Oxaliplatin sensitizes human colon cancer cells to TRAIL through JNK-dependent phosphorylation of Bcl-xL.
El Fajoui Z; Toscano F; Jacquemin G; Abello J; Scoazec JY; Micheau O; Saurin JC
Gastroenterology; 2011 Aug; 141(2):663-73. PubMed ID: 21683075
[TBL] [Abstract][Full Text] [Related]
13. Disruption of signaling through SEK1 and MKK7 yields differential responses in hypoxic colon cancer cells treated with oxaliplatin.
Vasilevskaya IA; Selvakumaran M; O'Dwyer PJ
Mol Pharmacol; 2008 Jul; 74(1):246-54. PubMed ID: 18436711
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
